American Chemical Society
Division of Medicinal Chemistry
2008 Officers
Chair - James R. McCarthy, Ph.D., Drop Code 1920, 1 Lilly Corporate Center, Indianapolis, IN 46285-0002, (317) 433-1345, jmccarthy@lilly.com
Vice Chair - Laurence Hurley, Ph.D., Keating Bioresearch Building 102, 1657 E. Helen St., University of Arizona, Tucson, AZ 85721, (520) 626-5622 hurley@pharmacy.arizona.edu
Program Chair - Jeff Zablocki, Ph.D., CV Therapeutics, Inc., 3172 Porter Drive, Palo Alto, CA 94304, 650-384-8547 jeff.zablocki@cvt.com
Secretary and Public Relations Officer 2008-2010 - Patrick M. Woster, Ph.D., 3132 Applebaum Hall, Wayne State University, Detroit, MI 48202, Voice: (313)-577-1523, FAX: (313)-577-2033, pwoster@wayne.edu
Membership Chair - Yanping Xu, Ph.D., Lilly Research Laboratories, Lilly Corporate Center, DC 1910, Indianapolis, IN 46285, (317) 433-1113, Fax: (317) 433-0541, xu_yanping@lilly.com
Treasurer 2009-2011 - Danny L. Lattin, Ph.D., 4950 Research Park Way, Lawrence, KS 66047 USA (785) 843-3460, lattind@ku.edu
Academic Councilor 2008-2010 - Richard A. Gibbs, Ph.D., Department of Medicinal Chemistry and Molecular Pharmacology, 575 Stadium Mall Drive, Purdue University, West Lafayette, IN 47907-2091, (765) 494-1456, rag@pharmacy.purdue.edu
Academic Councilor 2009-2011 - Wendel L. Nelson, Ph.D., Department of Medicinal Chemistry, College of Pharmacy, University of Washington, Seattle, WA, 98195-7610, (206) 543-2209 wlnelson@u.washington.edu
Industrial Councilor 2007-2009 - Ravi Nargund, Ph.D., Merck Research Laboratories, RY 50G-301, P.O. Box 2000, Rahway, NJ 07065, (732) 594-3704, ravi_nargund@merck.com
Industrial Councilor 2009-2011 - William Greenlee, Ph.D., Schering-Plough Research Institute, K15-3, 2015 Galloping Hill Road, Kenilworth, NJ 07033, (908) 740-2220 william.greenlee@spcorp.com
Past Chair - Donald J. Abraham, Ph.D., Department of Medicinal Chemistry, Virginia Commonwealth University, 410 N. 12th Street, Richmond, VA 23298-0581, (804) 828-8183, dabraham@vcu.edu
Alternate Councilors, Members-at-Large and Ad Hoc Members
Academic Alternate Councilor 2008-2010 - Richard A. Glennon, Ph.D., Department of Medicinal Chemistry, Virginia Commonwealth University, 410 N. 12th Street, Richmond, VA 23298-0581, (804) 828-8487, glennon@vcu.edu
Academic Alternate Councilor 2009-2011 - Thomas E. Prisinzano, Ph.D., Department of Medicinal Chemistry, University of Kansas, 1251 Wescoe Hall Dr., 4070 Malott Hall, Lawrence, KS 66045-7582, 785-864-3267, prisinza@ku.edu
Industrial Alternate Councilor 2007-2009 - Jasbir Singh, Ph.D., Vice-President, Medicinal Chemistry, deCODE Chemistry, Inc., 2501 Davey Road, Woodridge, IL-60517, 630-783-4915, jsingh@decode.com
Industrial Alternate Councilor 2009-2011 - Peter R. Bernstein, Ph.D. Department of Chemistry, AstraZeneca Pharmaceuticals, 1800 Concord Pike, Wilmington, DE 19803, (302) 886-8966, peter.bernstein@astrazeneca.com
EFMC Liaison (Ad Hoc) 2009 - Thomas J. Perun, Ph.D., 47731 Old Houston Hwy, Hempstead, TX 77445, tjperun@aol.com
Member-at-Large (Ad Hoc) 2008-2009 - Andrew Stamford, Schering Plough Research Institute, K15-2545, 2015 Galloping Hill Road, Kenilworth NJ, 07033, (908) 740-3481, Andrew.Stamford@spcorp.com
Member-at-Large (Ad Hoc) 2008-2009 - Yusuf Abul-Hajj, Department of Medicinal Chemistry, 308 Harvard St. S.E., 9-151 Weaver-Densford Hall, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, (612) 624-5987, abulh001@umn.edu
Editor-in-Chief, Annual Reports in Medicinal Chemistry 2007-2011 - John E. Macor, Ph.D., Executive Director, Neuroscience Discovery Chemistry, Bristol-Myers Squibb, 5 Research Parkway, Wallingford, CT 06492, (203) 677-7092, john.macor@bms.com
